No manufacturer will have a coronavirus vaccine ready for use before the middle of 2020, despite an intensive global effort, a biotech executive told AFP on Friday.
Jan 31, 2020
0
979
How does SARS-CoV-2 evade our immune defenses? It's a good question, actually. When SARS-CoV-2 defeats host defenses, we need to know how it does so, and conversely, when host defenses prevail, that also needs to be understood. ...
As we age, the end caps of our chromosomes, called telomeres, gradually shorten. Now, Salk scientists have discovered that when telomeres become very short, they communicate with mitochondria, the cell's powerhouses. This ...
Feb 8, 2023
0
323
A new study from the Scripps Research laboratory of Sathyanarayanan Puthanveettil, Ph.D., peers deep within the nucleus of developing brain cells and finds that long noncoding RNAs play an important role in the healthy functioning ...
Oct 9, 2018
0
321
When cells copy DNA to produce RNA transcripts, they include only some chunks of genetic material known as exons and throw out the rest. The resulting product is a fully-mature RNA molecule, which can be used as a template ...
Feb 9, 2023
0
66
Patients with Huntington's disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.
Feb 12, 2018
0
282
Most medical disorders have well-defined physical characteristics seen in tissues, organs and bodily fluids. Psychiatric disorders, in contrast, are not defined by such pathology, but rather by behavior.
Feb 8, 2018
0
317
At the 96th General Session of the International Association for Dental Research (IADR), held in conjunction with the IADR Pan European Regional (PER) Congress, David Wong, University of California, Los Angeles, USA along ...
Jul 26, 2018
0
1
Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.
Mar 11, 2024
0
70
A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.
Jan 28, 2020
0
351
